- Home
- EVOK vs FGNX Comparison
EVOK vs FGNX Comparison
Compare EVOK & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- FGNX
- Stock Information
- Founded
- EVOK 2007
- FGNX 1932
- Country
- EVOK United States
- FGNX United States
- Employees
- EVOK 3
- FGNX N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- FGNX Property-Casualty Insurers
- Sector
- EVOK Health Care
- FGNX Finance
- Exchange
- EVOK Nasdaq
- FGNX Nasdaq
- Market Cap
- EVOK 7.6M
- FGNX 5.1M
- IPO Year
- EVOK 2013
- FGNX N/A
- Fundamental
- Price
- EVOK $4.90
- FGNX $4.12
- Analyst Decision
- EVOK
- FGNX Strong Buy
- Analyst Count
- EVOK 0
- FGNX 1
- Target Price
- EVOK N/A
- FGNX $8.00
- AVG Volume (30 Days)
- EVOK 27.4K
- FGNX 1.2M
- Earning Date
- EVOK 11-07-2025
- FGNX 11-19-2025
- Dividend Yield
- EVOK N/A
- FGNX N/A
- EPS Growth
- EVOK N/A
- FGNX N/A
- EPS
- EVOK N/A
- FGNX 2.41
- Revenue
- EVOK $12,794,859.00
- FGNX $24,184,000.00
- Revenue This Year
- EVOK $57.38
- FGNX N/A
- Revenue Next Year
- EVOK $59.57
- FGNX N/A
- P/E Ratio
- EVOK N/A
- FGNX $1.68
- Revenue Growth
- EVOK 70.02
- FGNX 24.03
- 52 Week Low
- EVOK $1.94
- FGNX $3.35
- 52 Week High
- EVOK $12.32
- FGNX $41.25
- Technical
- Relative Strength Index (RSI)
- EVOK 52.02
- FGNX N/A
- Support Level
- EVOK $4.53
- FGNX N/A
- Resistance Level
- EVOK $4.69
- FGNX N/A
- Average True Range (ATR)
- EVOK 0.27
- FGNX 0.00
- MACD
- EVOK 0.06
- FGNX 0.00
- Stochastic Oscillator
- EVOK 61.43
- FGNX 0.00
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About FGNX Fundamental Global Inc. Common Stock
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.